» Articles » PMID: 15481637

Post-challenge Hyperglycaemia Rather Than Fasting Hyperglycaemia is an Independent Risk Factor of Cardiovascular Disease Events

Overview
Journal Clin Lab
Specialty Pathology
Date 2004 Oct 16
PMID 15481637
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Evidence accumulated from several large-scale epidemiological and intervention studies strongly indicates that hyperglycaemia and specifically post-challenge hyperglycaemia is an independent factor related to the increased risks of cardiovascular disease. The DECODE (Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe) study has de-emphasized the importance of fasting glucose, in contrast to post-challenge hyperglycaemia, as the principal measurable determinant of glycaemic exposure contributing to the risk of cardiovascular disease in Type 2 diabetes and even in non-diabetic subjects. The study, based on five Finnish DECODE study cohorts, demonstrated that in subjects without previous myocardial infarction, 2-h post-challenge glucose after an oral glucose tolerance test was a stronger predictor of the risk of serious coronary heart disease events than fasting glucose. Post-challenge hyperglycaemia was identified as an independent risk factor for cardiovascular disease also in Cardiovascular Health Study and the Framingham Offspring Study. It seems fair to conclude that post-challenge glucose is likely to be an independent cardiovascular risk factor. The mechanism for the increased risk in the incidence and mortality related to post-challenge hyperglycaemia has been speculated. To recognize that post-challenge hyperglycaemia is an important risk factor for cardiovascular disease may be of a significant preventive importance.

Citing Articles

Development and Validation of a Risk Prediction Model for Ketosis-Prone Type 2 Diabetes Mellitus Among Patients Newly Diagnosed with Type 2 Diabetes Mellitus in China.

Jiang Y, Zhu J, Lai X Diabetes Metab Syndr Obes. 2023; 16:2491-2502.

PMID: 37614378 PMC: 10443636. DOI: 10.2147/DMSO.S424267.


Newly diagnosed glucose intolerance and prognosis after acute myocardial infarction: comparison of post-challenge versus fasting glucose concentrations.

Tamita K, Katayama M, Takagi T, Yamamuro A, Kaji S, Yoshikawa J Heart. 2012; 98(11):848-54.

PMID: 22581733 PMC: 3351853. DOI: 10.1136/heartjnl-2012-301629.


Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.

Sarwar N, Gao P, Kondapally Seshasai S, Gobin R, Kaptoge S, Di Angelantonio E Lancet. 2010; 375(9733):2215-22.

PMID: 20609967 PMC: 2904878. DOI: 10.1016/S0140-6736(10)60484-9.


Cardiovascular disease in diabetes.

Bloomgarden Z Diabetes Care. 2010; 33(4):e49-54.

PMID: 20351221 PMC: 6898908. DOI: 10.2337/dc10-zb04.


Heart disease risk factors in midlife predict subclinical coronary atherosclerosis more than 25 years later in survivors without clinical heart disease: the Rancho Bernardo Study.

Barrett-Connor E, Bergstrom J, Wright M, Kramer C J Am Geriatr Soc. 2009; 57(6):1041-4.

PMID: 19507296 PMC: 2701669. DOI: 10.1111/j.1532-5415.2009.02268.x.